ITGB2 and diabetes mellitus: The mechanism by which the RAGE-Mac-1 interaction mediates leukocyte recruitment is applicable to pathophysiological conditions related to high RAGE expression, such as diabetes, chronic immune response, atherosclerosis or cancer.